Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Exhaled nitric oxide can't replace the methacholine challenge in suspected pediatric asthma.

Keßler A, Kragl U, Glass Ä, Schmidt S, Fischer DC, Ballmann M.

Respir Med. 2019 Oct;157:21-25. doi: 10.1016/j.rmed.2019.08.008. Epub 2019 Aug 27.

PMID:
31476569
2.

Akute pulmonale Infektionen – was ist wann typisch?

Ballmann M.

Rofo. 2019 Sep;191(S 02):S105. doi: 10.1055/a-0943-0945. Epub 2019 Aug 20. German. No abstract available.

PMID:
31430770
Free Article
3.

Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis.

Seidl E, Kiermeier H, Liebisch G, Ballmann M, Hesse S, Paul-Buck K, Ratjen F, Rietschel E, Griese M.

J Cyst Fibros. 2019 Apr 24. pii: S1569-1993(18)30860-9. doi: 10.1016/j.jcf.2019.04.012. [Epub ahead of print]

PMID:
31029606
4.

Suitability of growth standards for growth monitoring in children with genetic diseases.

Duran I, Martakis K, Stark C, Ballmann M, Hamacher S, Schoenau E, Semler O, Hellmich M.

Anthropol Anz. 2019 Mar 28;76(1):15-28. doi: 10.1127/anthranz/2019/0932. Epub 2019 Jan 15.

PMID:
30648187
5.

Treatment of cystic fibrosis-related diabetes - Authors' reply.

Ballmann M, Holl RW.

Lancet Diabetes Endocrinol. 2018 Mar;6(3):167-168. doi: 10.1016/S2213-8587(18)30043-3. No abstract available.

PMID:
29475493
6.

Umpolung at Boron: Ancillary-Ligand-Induced Formation of Boron-Based Donor Ligands from Phosphine-Boranes.

Vondung L, Alig L, Ballmann M, Langer R.

Chemistry. 2018 Aug 22;24(47):12346-12353. doi: 10.1002/chem.201705847. Epub 2018 Mar 22.

PMID:
29389052
7.

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial.

Ballmann M, Hubert D, Assael BM, Staab D, Hebestreit A, Naehrlich L, Nickolay T, Prinz N, Holl RW; CFRD Study Group.

Lancet Diabetes Endocrinol. 2018 Feb;6(2):114-121. doi: 10.1016/S2213-8587(17)30400-X. Epub 2017 Dec 5. Erratum in: Lancet Diabetes Endocrinol. 2019 Apr;7(4):e4.

PMID:
29199116
8.

Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.

Duffy MR, Alonso-Padilla J, John L, Chandra N, Khan S, Ballmann MZ, Lipiec A, Heemskerk E, Custers J, Arnberg N, Havenga M, Baker AH, Lemckert A.

J Gen Virol. 2018 Jan;99(1):135-147. doi: 10.1099/jgv.0.000978. Epub 2017 Nov 20.

PMID:
29154744
9.

The use of high-flow nasal cannula (HFNC) as respiratory support in neonatal and pediatric intensive care units in Germany - A nationwide survey.

Schmid F, Olbertz DM, Ballmann M.

Respir Med. 2017 Oct;131:210-214. doi: 10.1016/j.rmed.2017.08.027. Epub 2017 Sep 1.

PMID:
28947032
10.
11.

Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.

Junge S, Görlich D, den Reijer M, Wiedemann B, Tümmler B, Ellemunter H, Dübbers A, Küster P, Ballmann M, Koerner-Rettberg C, Große-Onnebrink J, Heuer E, Sextro W, Mainz JG, Hammermann J, Riethmüller J, Graepler-Mainka U, Staab D, Wollschläger B, Szczepanski R, Schuster A, Tegtmeyer FK, Sutharsan S, Wald A, Nofer JR, van Wamel W, Becker K, Peters G, Kahl BC.

PLoS One. 2016 Nov 18;11(11):e0166220. doi: 10.1371/journal.pone.0166220. eCollection 2016.

12.

Crystal structure of raptor adenovirus 1 fibre head and role of the beta-hairpin in siadenovirus fibre head domains.

Nguyen TH, Ballmann MZ, Do HT, Truong HN, Benkő M, Harrach B, van Raaij MJ.

Virol J. 2016 Jun 22;13:106. doi: 10.1186/s12985-016-0558-7.

13.

Using the E4orf6-Based E3 Ubiquitin Ligase as a Tool To Analyze the Evolution of Adenoviruses.

Gilson T, Blanchette P, Ballmann MZ, Papp T, Pénzes JJ, Benkő M, Harrach B, Branton PE.

J Virol. 2016 Jul 27;90(16):7350-7367. doi: 10.1128/JVI.00420-16. Print 2016 Aug 15.

14.

Nickel-Catalyzed Double Bond Transposition of Alkenyl Boronates for in Situ syn-Selective Allylboration Reactions.

Weber F, Ballmann M, Kohlmeyer C, Hilt G.

Org Lett. 2016 Feb 5;18(3):548-51. doi: 10.1021/acs.orglett.5b03585. Epub 2016 Jan 15.

PMID:
26771707
15.

Structure and Sialyllactose Binding of the Carboxy-Terminal Head Domain of the Fibre from a Siadenovirus, Turkey Adenovirus 3.

Singh AK, Berbís MÁ, Ballmann MZ, Kilcoyne M, Menéndez M, Nguyen TH, Joshi L, Cañada FJ, Jiménez-Barbero J, Benkő M, Harrach B, van Raaij MJ.

PLoS One. 2015 Sep 29;10(9):e0139339. doi: 10.1371/journal.pone.0139339. eCollection 2015.

16.

Crystal structure of the fibre head domain of bovine adenovirus 4, a ruminant atadenovirus.

Nguyen TH, Vidovszky MZ, Ballmann MZ, Sanz-Gaitero M, Singh AK, Harrach B, Benkő M, van Raaij MJ.

Virol J. 2015 May 22;12:81. doi: 10.1186/s12985-015-0309-1.

17.

High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: a multicenter screening study.

Scheuing N, Holl RW, Dockter G, Hermann JM, Junge S, Koerner-Rettberg C, Naehrlich L, Smaczny C, Staab D, Thalhammer G, van Koningsbruggen-Rietschel S, Ballmann M.

PLoS One. 2014 Nov 13;9(11):e112578. doi: 10.1371/journal.pone.0112578. eCollection 2014.

18.

Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.

Koerner-Rettberg C, Ballmann M.

Core Evid. 2014 Sep 19;9:99-112. doi: 10.2147/CE.S64980. eCollection 2014. Review.

19.

A novel siadenovirus detected in the kidneys and liver of Gouldian finches (Erythura gouldiae).

Joseph HM, Ballmann MZ, Garner MM, Hanley CS, Berlinski R, Erdélyi K, Childress AL, Fish SS, Harrach B, Wellehan JF Jr.

Vet Microbiol. 2014 Aug 6;172(1-2):35-43. doi: 10.1016/j.vetmic.2014.04.006. Epub 2014 Apr 21.

PMID:
24814929
20.

Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.

Ballmann M, Hubert D, Assael BM, Kronfeld K, Honer M, Holl RW; CFRD Study group.

BMC Pediatr. 2014 Mar 11;14:70. doi: 10.1186/1471-2431-14-70.

21.

Quality of life is associated with physical activity and fitness in cystic fibrosis.

Hebestreit H, Schmid K, Kieser S, Junge S, Ballmann M, Roth K, Hebestreit A, Schenk T, Schindler C, Posselt HG, Kriemler S.

BMC Pulm Med. 2014 Feb 27;14:26. doi: 10.1186/1471-2466-14-26.

22.

Diabetes in cystic fibrosis: multicenter screening results based on current guidelines.

Scheuing N, Holl RW, Dockter G, Fink K, Junge S, Naehrlich L, Smaczny C, Staab D, Thalhammer G, van Koningsbruggen-Rietschel S, Ballmann M.

PLoS One. 2013 Dec 6;8(12):e81545. doi: 10.1371/journal.pone.0081545. eCollection 2013.

23.

Crystallization of the C-terminal head domain of the fibre protein from a siadenovirus, turkey adenovirus 3.

Singh AK, Ballmann MZ, Benkő M, Harrach B, van Raaij MJ.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Oct;69(Pt 10):1135-9. doi: 10.1107/S174430911302397X. Epub 2013 Sep 28.

24.

Whole-genome sequences of two turkey adenovirus types reveal the existence of two unknown lineages that merit the establishment of novel species within the genus Aviadenovirus.

Marek A, Ballmann MZ, Kosiol C, Harrach B, Schlötterer C, Hess M.

J Gen Virol. 2014 Jan;95(Pt 1):156-70. doi: 10.1099/vir.0.057711-0. Epub 2013 Sep 28.

PMID:
24077297
25.

Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.

Naehrlich L, Ballmann M, Davies J, Derichs N, Gonska T, Hjelte L, van Konigsbruggen-Rietschel S, Leal T, Melotti P, Middleton P, Tümmler B, Vermeulen F, Wilschanski M; ECFS Diagnostic Network Working Group.

J Cyst Fibros. 2014 Jan;13(1):24-8. doi: 10.1016/j.jcf.2013.08.006. Epub 2013 Sep 7.

26.

Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.

Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M.

J Cyst Fibros. 2014 Jan;13(1):80-5. doi: 10.1016/j.jcf.2013.06.001. Epub 2013 Jun 25.

27.

Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial.

Griese M, Kappler M, Eismann C, Ballmann M, Junge S, Rietschel E, van Koningsbruggen-Rietschel S, Staab D, Rolinck-Werninghaus C, Mellies U, Köhnlein T, Wagner T, König S, Teschler H, Heuer HE, Kopp M, Heyder S, Hammermann J, Küster P, Honer M, Mansmann U, Beck-Speier I, Hartl D, Fuchs C; Glutathione Study Group, Hector A.

Am J Respir Crit Care Med. 2013 Jul 1;188(1):83-9. doi: 10.1164/rccm.201303-0427OC.

PMID:
23631796
28.

Effect of supervised training on FEV1 in cystic fibrosis: a randomised controlled trial.

Kriemler S, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Stüssi C, Hebestreit H.

J Cyst Fibros. 2013 Dec;12(6):714-20. doi: 10.1016/j.jcf.2013.03.003. Epub 2013 Apr 13.

29.

Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome.

Griese M, Heinrich S, Ratjen F, Kabesch M, Paul K, Ballmann M, Rietschel E, Kappler M.

PLoS One. 2012;7(12):e51050. doi: 10.1371/journal.pone.0051050. Epub 2012 Dec 7.

30.

Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites.

Bielecki P, Komor U, Bielecka A, Müsken M, Puchałka J, Pletz MW, Ballmann M, Martins dos Santos VA, Weiss S, Häussler S.

Environ Microbiol. 2013 Feb;15(2):570-87. doi: 10.1111/1462-2920.12024. Epub 2012 Nov 12.

PMID:
23145907
31.

Calculation of the capnographic index based on expiratory molar mass-volume-curves--a suitable tool to screen for cystic fibrosis lung disease.

Fuchs SI, Junge S, Ellemunter H, Ballmann M, Gappa M.

J Cyst Fibros. 2013 May;12(3):277-83. doi: 10.1016/j.jcf.2012.08.011. Epub 2012 Sep 12.

32.

Immunochemical analysis of mutant CFTR in lung explants.

van Barneveld A, Zander I, Hyde R, Länger F, Simon A, Krüger M, Ballmann M, Derichs N, Tümmler B.

Cell Physiol Biochem. 2012;30(3):587-95. doi: 10.1159/000341440. Epub 2012 Jul 25.

33.

Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics.

Ballmann M, Smyth A, Geller DE.

Respir Med. 2011 Dec;105 Suppl 2:S2-8. doi: 10.1016/S0954-6111(11)70021-X.

34.

Applying clinical outcome variables to appropriate aerosolized antibiotics for the treatment of patients with cystic fibrosis.

VanDevanter DR, Ballmann M, Flume PA.

Respir Med. 2011 Dec;105 Suppl 2:S18-23. doi: 10.1016/S0954-6111(11)70023-3.

35.

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, De Boeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, Ordoñez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW.

Thorax. 2012 Jan;67(1):12-8. doi: 10.1136/thoraxjnl-2011-200393. Epub 2011 Aug 8.

36.

Prognostic relevance of hypoglycemia following an oral glucose challenge for cystic fibrosis-related diabetes.

Radike K, Molz K, Holl RW, Poeter B, Hebestreit H, Ballmann M.

Diabetes Care. 2011 Apr;34(4):e43. doi: 10.2337/dc10-2286. No abstract available.

37.

Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia.

Stanke F, Becker T, Kumar V, Hedtfeld S, Becker C, Cuppens H, Tamm S, Yarden J, Laabs U, Siebert B, Fernandez L, Macek M Jr, Radojkovic D, Ballmann M, Greipel J, Cassiman JJ, Wienker TF, Tümmler B.

J Med Genet. 2011 Jan;48(1):24-31. doi: 10.1136/jmg.2010.080937. Epub 2010 Sep 12.

38.

Functional analysis of F508del CFTR in native human colon.

van Barneveld A, Stanke F, Tamm S, Siebert B, Brandes G, Derichs N, Ballmann M, Junge S, Tümmler B.

Biochim Biophys Acta. 2010 Nov;1802(11):1062-9. doi: 10.1016/j.bbadis.2010.08.001. Epub 2010 Aug 7.

39.

Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data.

Derichs N, Sanz J, Von Kanel T, Stolpe C, Zapf A, Tümmler B, Gallati S, Ballmann M.

Thorax. 2010 Jul;65(7):594-9. doi: 10.1136/thx.2009.125088.

PMID:
20627915
40.

Pulmonary retransplantation in paediatric patients: a justified therapeutic option? A single-centre experience.

Müller C, Görler H, Ballmann M, Gottlieb J, Simon AR, Strüber M, Hansen G.

Eur J Cardiothorac Surg. 2011 Feb;39(2):201-5. doi: 10.1016/j.ejcts.2010.05.012. Epub 2010 Jul 6.

PMID:
20609595
41.

Short-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis.

Fuchs SI, Toussaint S, Edlhaimb B, Ballmann M, Gappa M.

Pediatr Pulmonol. 2010 Mar;45(3):301-6. doi: 10.1002/ppul.21180.

PMID:
20146388
42.

Minimal acute rejection in pediatric lung transplantation--does it matter?

Benden C, Faro A, Worley S, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet SC, Danziger-Isakov LA.

Pediatr Transplant. 2010 Jun;14(4):534-9. doi: 10.1111/j.1399-3046.2009.01268.x. Epub 2010 Jan 4.

43.

Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis.

Brinkmann F, Schwerk N, Hansen G, Ballmann M.

Allergy. 2010 Jan;65(1):134-5. doi: 10.1111/j.1398-9995.2009.02147.x. No abstract available.

PMID:
19804448
44.

Size reduction of donor organs in pediatric lung transplantation.

Mueller C, Hansen G, Ballmann M, Schwerk N, Simon AR, Goerler H, Strueber M.

Pediatr Transplant. 2010 May;14(3):364-8. doi: 10.1111/j.1399-3046.2009.01242.x. Epub 2009 Sep 28.

PMID:
19793226
45.

Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.

Ranganathan K, Worley S, Michaels MG, Arrigan S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB Jr, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet SC, Faro A, Danziger-Isakov L.

J Heart Lung Transplant. 2009 Oct;28(10):1050-6. doi: 10.1016/j.healun.2009.04.032.

46.

Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis.

Riethmueller J, Junge S, Schroeter TW, Kuemmerer K, Franke P, Ballmann M, Claass A, Broemme S, Jeschke R, Hebestreit A, Staab D, Koetz K, Doering G, Stern M.

Infection. 2009 Oct;37(5):418-23. doi: 10.1007/s15010-009-8116-5. Epub 2009 Sep 5.

PMID:
19756419
47.

Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients.

Riethmueller J, Ballmann M, Schroeter TW, Franke P, von Butler R, Claass A, Junge S, Doering G, Stern M; German Multicenter Study Group.

Infection. 2009 Oct;37(5):424-31. doi: 10.1007/s15010-009-8117-4. Epub 2009 Sep 5.

PMID:
19756418
48.

[Lung transplantation in cystic fibrosis--a position paper].

Gottlieb J, Ballmann M, von Mallinckrodt C, Staab D, Smaczny C, Simon A, Welte T, Wagner TO.

Pneumologie. 2009 Aug;63(8):451-60. doi: 10.1055/s-0029-1214821. Epub 2009 Aug 7. Review. German.

49.

Long-term effects of a partially supervised conditioning programme in cystic fibrosis.

Hebestreit H, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Schenk T, Posselt HG, Kriemler S.

Eur Respir J. 2010 Mar;35(3):578-83. doi: 10.1183/09031936.00062409. Epub 2009 Jul 30.

50.

The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.

Danziger-Isakov LA, Worley S, Michaels MG, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet S, Faro A.

Transplantation. 2009 May 27;87(10):1541-8. doi: 10.1097/TP.0b013e3181a492e8.

Supplemental Content

Loading ...
Support Center